Abstract
Hsp104p, as an anti-oxidative protector of ROS generation, was examined to inquire if it prevents aggregation of synuclein mutants, A30P or A53T upon aging, in vitro. The role of Hsp104p was also addressed in dissociation of pre-formed aggregates of synuclein mutants. Significant protection in fibril formation was observed by wild-type Hsp104p regardless of ATP presence, not by mutant Hsp104p. To a lesser extent, the dissociation effect of wild-type Hsp104p was observed only in the presence of ATP. These results will be discussed in relation to the development of an antioxidant approach to prevent amyloid fibril formation in several neurodegenerative diseases.
Keywords: hsp104p, molecular chaperone, synuclein, aggregation
Protein & Peptide Letters
Title: Regulation Of In Vitro Fibril Formation Of Synuclein Mutant Proteins By Hsp104p
Volume: 10 Issue: 5
Author(s): Byungmoon Kong, Young Kee Chae and Kyunghee Lee
Affiliation:
Keywords: hsp104p, molecular chaperone, synuclein, aggregation
Abstract: Hsp104p, as an anti-oxidative protector of ROS generation, was examined to inquire if it prevents aggregation of synuclein mutants, A30P or A53T upon aging, in vitro. The role of Hsp104p was also addressed in dissociation of pre-formed aggregates of synuclein mutants. Significant protection in fibril formation was observed by wild-type Hsp104p regardless of ATP presence, not by mutant Hsp104p. To a lesser extent, the dissociation effect of wild-type Hsp104p was observed only in the presence of ATP. These results will be discussed in relation to the development of an antioxidant approach to prevent amyloid fibril formation in several neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Kong Byungmoon, Chae Kee Young and Lee Kyunghee, Regulation Of In Vitro Fibril Formation Of Synuclein Mutant Proteins By Hsp104p, Protein & Peptide Letters 2003; 10 (5) . https://dx.doi.org/10.2174/0929866033478717
DOI https://dx.doi.org/10.2174/0929866033478717 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibitory Mechanisms of Antibiotics Targeting Elongation Factor Tu
Current Protein & Peptide Science Managing Acute Agitation and Psychotic Symptoms in the Emergency Department
Adolescent Psychiatry Amide-linked Ethanolamine Conjugate of Gemfibrozil as a Profound HDL Enhancer: Design, Synthesis, Pharmacological Screening and Docking Study
Current Drug Discovery Technologies Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Current Pharmacogenomics Gene-Gene Interactions in a Context of Individual Variability in Antipsychotic Drug Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine Nucleic Acid Aptamers Against Proteases
Current Medicinal Chemistry A Role for Leptin in the Systemic Inflammatory Response Syndrome (SIRS) and in Immune Response, an Update
Current Medicinal Chemistry Enhancement of Hippocampal Plasticity by Physical Exercise as a Polypill for Stress and Depression: A Review
CNS & Neurological Disorders - Drug Targets Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?
Current Pharmaceutical Design Deterioration of Executive Functioning in Chronic Ecstasy Users: Evidence for Multiple Drugs Effects
Current Drug Abuse Reviews Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Neuritin, A Neurotrophic Factor in Nervous System Physiology
Current Medicinal Chemistry Adiposity and Alzheimers Disease
Current Alzheimer Research Commentary-1 Research Highlights (Never Underestimate the Power of Adenosine in Multiple Sclerosis)
CNS & Neurological Disorders - Drug Targets Neurogenic Ejaculatory Disorders: Focus on Current and Future Treatments
Recent Patents on CNS Drug Discovery (Discontinued) SAR, QSAR and Docking of Anticancer Flavonoids and Variants: A Review
Current Topics in Medicinal Chemistry Safety and Efficacy of Setarud (IMOD TM ) Among People Living with HIV/AIDS: A Review
Recent Patents on Anti-Infective Drug Discovery Vitamin D-Binding Protein Acts in the Actin Scavenge System and Can Have Increased Expression During Aspirin Therapy
Current Neurovascular Research Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?
Current Pharmaceutical Design ITK Inhibitors in Inflammation and Immune-Mediated Disorders
Current Topics in Medicinal Chemistry